| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |